The rapid spread of the global epidemic of new crown pneumonia has led to a surge in demand for masks, respirators, protective clothing and other medical supplies, while China, as the “world's factory”, is still in short supply despite the fact that it is running at full capacity. The Global Times reporter through the investigation found that the production of some of the key components required to rely on imports is one of the reasons. Germany's “Wirtschaftswoche” that “the epidemic will become a catalyst for China's investment in biomedical technology”. However, unlike the previous focus on the acquisition of large overseas medical enterprises, due to the tightening of investment rules in Europe and the United States on the “key industries”, including the medical industry, Chinese investors have been increasingly targeting the industry's “hidden champions”.